Trump Trade: Should You Buy the Biotech Dips?

The video discusses the impact of political rhetoric on the biotech sector, focusing on pricing pressures and innovation. It highlights the importance of distinguishing between companies with strong fundamentals and those affected by headlines. The discussion also covers potential political impacts on drug pricing and investment opportunities in biotech, particularly in companies like Celgene and Alnylam.

What are the key factors that the speaker believes will drive innovation in the biotech sector?

What potential outcomes does the speaker foresee if Hillary Clinton had been elected regarding drug pricing?